High plasma adiponectin concentration is associated with all-cause mortality in patients with carotid atherosclerosis

Jonas Persson1, Lasse Folkersen, Johan Ekstrand

  • 1Division of Cardiovascular Medicine, Department of Clinical Sciences, Karolinska Institutet, Danderyd University Hospital, Sweden. jonas.persson@ds.se

Atherosclerosis
|October 25, 2012
PubMed

Insights

High adiponectin levels are linked to increased mortality in patients with carotid artery stenosis. However, adiponectin did not predict recurrent ischemic cardiovascular events in this patient group.

Area of Science:

  • Cardiovascular Medicine
  • Endocrinology
  • Biomarkers

Background:

  • The prognostic value of adiponectin in carotid artery disease remains unclear.
  • Investigating adiponectin's role in mortality and ischemic events is crucial for risk stratification.

Purpose of the Study:

  • To determine if plasma adiponectin concentrations predict mortality and recurrent ischemic cardiovascular events in patients undergoing carotid endarterectomy.

Main Methods:

  • A cohort of 292 patients undergoing carotid endarterectomy was studied.
  • Plasma adiponectin levels were measured at baseline.
  • Cox regression models were used to assess the risk of mortality and ischemic events over a median follow-up of 5.2 years.

Main Results:

  • High adiponectin levels were independently associated with increased mortality (HR per SD increase: 1.73).
  • Adiponectin was not significantly associated with recurrent ischemic cardiovascular events (HR per SD increase: 0.96).
  • Factors like age, type 2 diabetes mellitus, and coronary heart disease were also associated with mortality.

Conclusions:

  • Elevated plasma adiponectin is associated with mortality in patients with carotid artery stenosis undergoing surgery.
  • Adiponectin may serve as a mortality biomarker but not for ischemic events in this population.
  • Further research is needed to validate adiponectin's role as a prognostic biomarker.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...